Bovine papillomavirus type 4 (BPV-4) is a mucosal epitheliotropic virus that is a causative agent in alimentary carcinoma of cattle. The long control region (LCR) of this virus controls expression of the transforming proteins, E8 and E7. Deletion mutants of the LCR were prepared and assayed for their ability to activate transcription from the LCR promoter in primary bovine palate keratinocytes (the natural target cell for BPV-4) and fibroblasts. The LCR was at least an order of magnitude more active in keratinocytes than in fibroblasts. An epithelial specific enhancer was identified that activated transcription from the SV40 promoter to levels identical to the full-length LCR. One of the active sites in the enhancer is 100 % conserved in the LCR of human papillomavirus type 16. The results demonstrate that the BPV-4 LCR has an epithelial specific enhancer, which offers the opportunity to study epithelial specific transcriptional regulation of papillomavirus promoters.
Bovine papillomavirus type 4 (BPV-4) is a mucosal epitheliotropic virus that is a causative agent in alimentary carcinoma of cattle. The long control region (LCR) of this virus controls expression of the transforming proteins, E8 and E7. Deletion mutants of the LCR were prepared and assayed for their ability to activate transcription from the LCR promoter in primary bovine palate keratinocytes (the natural target cell for BPV-4) and fibroblasts. The LCR was at least an order of magnitude more active in keratinocytes than in fibroblasts. An epithelial specific enhancer was identified that activated transcription from the SV40 promoter to levels identical to the full-length LCR. One of the active sites in the enhancer is 100 % conserved in the LCR of human papillomavirus type 16. The results demonstrate that the BPV-4 LCR has an epithelial specific enhancer, which offers the opportunity to study epithelial specific transcriptional regulation of papillomavirus promoters.
Human papillomaviruses (HPV) are causative agents of squamous cell carcinomas, with at least 90 % of cervical carcinomas containing HPV sequences (zur Hausen, 1991) . The mucosal epitheliotropic viruses HPV-16 and -18 are the most common viruses associated with cervical carcinoma and one of the mechanisms restricting these viruses to epithelial cell types involves transcriptional control. The transforming genes of these viruses, E6 and E7, are controlled by the long control region (LCR), which can be divided into three regions, the promoter region, the enhancer region and an area upstream of the enhancer that is apparently not involved in transcriptional regulation (Desaintes & Demeret, 1996) . The enhancer region of these viruses is epithelial specific, as it fails to activate transcription from heterologous promoters in non-epithelial cell types (Gloss et al., 1987) . A multiplicity of factors binds to Author for correspondence : Iain Morgan.
Fax j44 141 942 6521. e-mail i.morgan!beatson.gla.ac.uk these epithelial specific enhancers, including AP-1 (Offord & Beard, 1990 ; Thierry et al., 1992 ; Chong et al., 1991) , Oct-1 (Hoppe-Seyler et al., 1991 ; Morris et al., 1993) , NF1 (Apt et al., 1993 (Apt et al., , 1994 O'Connor & Bernard, 1995) , PEF-1 (Cuthill et al., 1993 ; Sibbet et al., 1995) , Sp1 (Apt et al., 1996) and YY1 (O'Connor et al., 1996 ; Dong et al., 1994) , although no one factor has been identified that determines the epithelial specific nature of these enhancer elements.
Bovine papillomavirus type 4 (BPV-4) is a mucosal epitheliotropic papillomavirus and is a causative agent of alimentary canal carcinoma in cattle (Campo et al., 1994) . Like HPV-16 and -18, the LCR of BPV-4 controls the expression of the transforming genes of the virus, E8 and E7. Although the distribution of E2 DNA-binding sites within the LCR is highly conserved between mucosal epitheliotropic papillomaviruses from different species, the overall sequence similarity is quite low (Morgan et al., 1998) . This suggests that BPV-4 uses a different combination of cellular factors from HPV-16 and -18 to control transcription from the LCR promoter. Previous studies have shown that the LCR of BPV-4 contains negative and positive control elements that regulate transcription from the TK promoter (Jackson & Campo, 1991) . However, it is not known whether the transcriptional control elements of this viral LCR are epithelial specific.
To investigate the regions of the LCR involved in regulating transcription from the BPV-4 LCR promoter, various deletion mutations were introduced into the LCR cloned upstream of the luciferase gene in the vector pGL3 (Promega). These constructs were used to identify elements in the LCR that contribute towards transcriptional activity in primary bovine palate keratinocytes (PalKs) and fibroblasts (PalFs), by transfecting these cells and determining the luciferase activity. The transfection and luciferase assay protocols for these cell types have been described previously (Morgan et al., 1998) account for 99 % of the transcriptional activity of the LCR in PalKs. In PalFs, the level of transcriptional activation was approximately 30-fold less than that seen in PalKs, although the overall pattern of transcriptional activity of the deletion mutants was similar.
In the HPV-16 and -18 LCRs, there are regions that function as epithelial specific enhancers when located upstream of heterologous promoters (Gloss et al., 1987) . The results presented in Fig. 1 suggest that the BPV-4 LCR contains an enhancer element between nucleotides 7131 and 44. To test this possibility, a DNA fragment from 7131 to 44 (178 bp) was PCR-amplified with Pfu1 (Stratagene) and cloned upstream of the SV40 promoter in the vector pGL3PRO (Promega), in both Fig. 2 . The BPV-4 LCR contains an epithelial specific enhancer. The two main sites contributing towards transcriptional activation (Fig. 1 b) were amplified by PCR and cloned upstream of the SV40 promoter in the vector pGL3PRO (see text for details). The resulting constructs were tested for their ability to activate transcription from the SV40 promoter in PalKs and PalFs. Ten µg of each plasmid was used in each experiment and the results are expressed as fold activation over pGL3PRO. The results represent at least three sets of experiments carried out in duplicate. SV, SV40 promoter alone ; LCR, full-length BPV-4 LCR cloned upstream of the SV40 promoter ; ENj, the area of the BPV-4 LCR from nucleotide 7131 to 44 (a total of 178 bp) cloned in the forward orientation upstream of the SV40 promoter ; EN-, the area of the BPV-4 LCR from nucleotide 7131 to 44 (a total of 178 bp) cloned in the reverse orientation upstream of the SV40 promoter.
the sense and anti-sense orientations, as a KpnI-HindIII fragment. The resulting constructs were sequenced and then assayed for transcriptional activity in PalKs and PalFs, and the results are shown in Fig. 2 . In the forward or reverse orientation, this fragment enhanced transcription from the SV40 promoter in PalKs 6-fold, which was an identical enhancement to that seen with the full-length LCR. The relative level of activation from the SV40 promoter was lower than that obtained with the BPV-4 promoter (Fig. 1) , as the background activity of the SV40 promoter was much higher in both keratinocytes and fibroblasts. The enhanced transcription was driven exclusively from the SV40 promoter, as the BPV-4 enhancer described here contains no transcriptional start sites (Jackson & Campo, 1995) . These results indicate that nucleotides 7131 to 44 contain the enhancer region of the BPV-4 LCR. From Fig. 2 it is also clear that the enhancer element of BPV-4 does not enhance transcriptional activation from the SV40 promoter in fibroblasts. This result is in agreement with studies of other epitheliotropic papillomavirus enhancers that operate in an epithelial cell type-specific manner (Desaintes & Demeret, 1996) .
To map the sequences that are important for the BPV-4 LCR enhancer function in more detail, further small deletions were introduced into Site1 and Site2. This was done by amplifying the sequences from the LCR, down to the promoter, by PCR with Pfu1 and cloning them in front of the luciferase gene. All of the constructs were sequenced and the transcriptional activities of the mutants were determined in PalKs. The results of these experiments are shown in Fig. 3 (a, b) , together with the sequences. For Site1, there are two regions that contributed to the drop in activity observed between ∆7131 and ∆7176 (which showed the same level of activity as ∆7180 shown in Fig. 1 Epithelial specific BPV-4 transcription Epithelial specific BPV-4 transcription two deletions, compared with a 3n1-fold drop observed in Fig.  1 with the same region deleted. For Site2, there were also regions that when deleted led to a loss of transcriptional activity : nucleotides 15 to 23 and 23 to 29, representing 14 nucleotides overall. The activity of ∆29 in Fig. 3 was the same as that for ∆44 in Fig. 1 . There is a sequence in the LCR of HPV-16 that is identical to a 9 bp sequence in Site2, TGTGTAAAG, which is highlighted in Fig. 3 (b) . This sequence is located at position 7800 in HPV-16, which lies outside the enhancer region, although there is a cellular protein that binds to this sequence (Nakshatri et al., 1990 ; Gloss et al., 1989) . The contribution made by this sequence to the transcriptional control of the HPV-16 LCR is not known, as the YY1 sites that repress the HPV-16 promoter make the study of this sequence difficult in the context of the HPV-16 promoter. To determine whether this sequence is responsible for the activity of Site2, mutations were introduced into the 9 bp region and the transcriptional activity of the mutants was assayed. The CF I. M. Morgan, G. J. Grindlay and M. S. Campo I. M. Morgan, G. J. Grindlay and M. S. Campo mutations and the results from these experiments are shown in Fig. 3 (c) , and it is clear that the 9 bp sequence is essential for transcriptional activity from Site2. The 9 bp sequence bears no close similarity to any known transcription factor-binding site.
The results demonstrate that the BPV-4 LCR has an organization typical of other mucosal epitheliotropic papillomavirus LCRs. There is a promoter region, an enhancer region and an area upstream that does not appear to contribute towards transcriptional regulation by cellular factors. The upstream binding site for the papillomavirus transcription factor E2, BS4, lies outside the enhancer region, as it does in the HPV-16 and -18 LCRs. The distribution of the E2 DNA-binding sites in mucosal epitheliotropic papillomavirus LCRs is highly conserved, indicating that the mechanism that E2 uses to regulate transcription is conserved (Morgan et al., 1998) . However, the cellular factors that BPV-4 uses to achieve epithelial specific transcriptional regulation may be distinct from those used by the HPVs. For example, there is no Sp1 site in the BPV-4 LCR upstream of the E2 sites proximal to the TATA box, as there is in HPV LCRs (Apt et al., 1996) . There are also no obvious AP-1 sites in the BPV-4 LCR, which is again distinct from the HPV LCRs, where these sites have a positive effect on transcription from adjacent papillomavirus promoters (Offord & Beard, 1990 ; Thierry et al., 1992 ; Chong et al., 1991) . However, there are several transcription factors that are implicated in transcriptional control from the HPV and BPV-4 LCRs. As mentioned above, the transcription factor family C\EBP has been implicated as both a positive and negative regulator of transcription from HPV and BPV-4 LCRs (Bauknecht et al., 1996 ; Bauknecht & Shi, 1998 ; McCaffery & Jackson, 1994 ; Wang et al., 1996) . Also, there are several putative binding sites for the NF1 transcription factor family in the BPV-4 LCR (Jackson & Campo, 1991) . It has been well documented that this family is involved in regulating transcription from HPV LCRs (Apt et al., 1993 (Apt et al., , 1994 O'Connor & Bernard, 1995) .
Exactly what combination of transcription factors is responsible for mediating the epithelial specific transcriptional regulation of papillomavirus LCRs remains to be established. It seems likely that a combination of ubiquitous factors, or specific members of transcription factor families, act in concert to establish a pattern of epithelial specific transcriptional regulation. Here, we have demonstrated that the BPV-4 LCR has an epithelial specific enhancer that has two main regions contributing towards this enhancer activity. Footprinting studies have demonstrated that cellular factors bind to these two regions (Jackson & Campo, 1991) . One of the sites, Site2, has a corresponding sequence in the LCR promoter region of HPV-16. Identification of the proteins involved and the contribution of the individual elements to epithelial specificity is under way. The BPV-4 LCR presents a further opportunity to study the mechanisms that mucosal epitheliotropic papillomaviruses use to achieve epithelial specific transcriptional regulation.
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